Delivery Order SPE2DB24D2205-SPE2DB25FDUNA

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,075.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $2,584.79. The contract is a Firm Fixed Price Delivery Order for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,435.49 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products, with a completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" to the Defense Logistics Agency (DLA). The $2,558.92 firm fixed-price delivery order contract has a completion date of December 11, 2024. The contract was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,741.59 firm fixed-price delivery order is for "REFRESH PLUS 0.5% EYE DROPS UD 70S", a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,739.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for "REFRESH PLUS 0.5% EYE DROPS 30S" and has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,776.00, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies. The contract has a firm fixed-price pricing type and an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,827.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products. The contract has an ultimate completion date of September 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,256.27 and is a delivery order for "REFRESH PLUS 0.5% EYE DROPS 30S". The contract is a firm fixed price, with an ultimate completion date of January 29, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $1,058.20 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a completion date of March 11, 2024. The contract was awarded on March 8, 2024 and is a Firm Fixed Price arrangement. There is no...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUNA
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,376.40, is for the delivery of 4566513198 "REFRESH PLUS 0.5% EYE DROPS UD 50S" medical supplies. The award is a Firm Fixed Price Delivery Order with a completion date of November 22, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/20/25, 9:15 AM